Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...
Abstract: Deep-learning-assisted antenna design methods such as surrogate models have gained significant popularity in recent years due to their potential to greatly increase design efficiencies by ...